2020
DOI: 10.1097/adm.0000000000000718
|View full text |Cite
|
Sign up to set email alerts
|

Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons

Abstract: Objectives: To describe how the novel coronavirus (COVID-19) pandemic has affected opioid agonist treatment (OAT) programs in jails and prisons. Methods: In May 2020, we conducted an online survey of 19 carceral systems that provided methadone and/or buprenorphine treatment for incarcerated populations before COVID-19. Eleven survey items examined challenges and changes to these programs as a result of the pandemic. Sixteen of 19 programs (84%) responde… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
44
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(48 citation statements)
references
References 6 publications
2
44
0
Order By: Relevance
“…Our results are consistent with key messages from the limited evidence base on respiratory infections in incarcerated populations (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(20)(21)(22). The interconnected nature of the residents of congregate institutions means that outbreaks, especially those that penetrate higher occupancy rooms, can quickly become building or prison outbreaks.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Our results are consistent with key messages from the limited evidence base on respiratory infections in incarcerated populations (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(20)(21)(22). The interconnected nature of the residents of congregate institutions means that outbreaks, especially those that penetrate higher occupancy rooms, can quickly become building or prison outbreaks.…”
Section: Discussionsupporting
confidence: 87%
“…Early releases reduce crowding but may cause public unrest ( 11 ). Curtailing in-prison activities (e.g., work or group therapy) limits mixing but is disruptive and may have adverse health effects ( 12 , 13 ). The federal government has issued guidance ( 14 , 15 ) on measures to reduce COVID-19 transmission in correctional settings, but the recommendations lack specificity and evidence of efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…The majority of papers were opinion pieces, with the exception of 10 case studies, [30][31][32][33][34][35][36][37][38][39] seven guidelines, 13-16 40-42 six literature reviews, [43][44][45][46][47][48] five qualitative studies, [49][50][51][52][53] three cross-sectional studies, [54][55][56] three briefings, [57][58][59] three case studies 37 39 60 and one study protocol. 61 All assessed studies were found to be of poor quality (see online supplemental appendix 3).…”
Section: Resultsmentioning
confidence: 99%
“… 1 The initial effect of the pandemic created widespread disruptions in the treatment of opioid use disorder (OUD), including in the provision of traditional outpatient services, prescription filling capabilities, 2 and jail-based treatment programs. 3 Additionally, recent survey data suggest that the pandemic and subsequent lockdowns may have created a negative psychological environment that has put many people with substance use disorders at risk for intensification of substance use. 4 , 5 The exact toll of these changes has yet to be calculated, however a recent national study of out-of-hospital cardiac arrests indicated an increase in opioid-related mortality compared to the prior year.…”
mentioning
confidence: 99%